Opioid Related Disorders

>

Latest News

The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.
FDA Approves First Naloxone Product for Over-the-Counter Use

March 30th 2023

The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.

From the impact of patients’ overdose deaths on physicians to addressing America’s mental health crisis, here are highlights from the week in Psychiatric Times.
The Week in Review: February 6-10

February 11th 2023

The Overdose Conundrum
The Overdose Conundrum

February 10th 2023

NDA Accepted for Nasal Nalmefene for Opioid Overdose
NDA Accepted for Nasal Nalmefene for Opioid Overdose

January 20th 2023

Drug Abuse Trends and Treatment Approaches for 2023
Drug Abuse Trends and Treatment Approaches for 2023

December 14th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.